iBio Inc (IBIO)

Name: iBio Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$0.0

Net Income

-$9.0M

Operating Margin

N/A

Free Cash Flow

-$15.3M

Debt / Assets

35.8%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for iBio Inc (IBIO).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-03-31	2024-12-31
Revenue	0	100,000	0	200,000
Cost of Revenue	241,000	289,000	0	0
Gross Profit	-241,000	-189,000	0	200,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	5,165,000	2,501,000	2,973,000	2,742,000
Operating Expenses	6,704,000	5,762,000	4,879,000	4,619,000
Operating Income	-6,945,000	-5,951,000	-4,879,000	-4,419,000
Interest Expense	41,000	36,000	54,000	57,000
Income Before Tax	-8,993,000	-5,720,000	-4,861,000	-4,364,000
Income Tax Expense	0	0	0	0
Net Income	-8,993,000	-5,720,000	-4,861,000	-4,364,000
Per Share
EPS	-0.09	-0.11	-0.49	-0.48
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for iBio Inc (IBIO).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Revenue	400,000	225,000	0	2,383,000	2,371,000
Cost of Revenue	0	1,250,000	1,106,000	216,000	1,462,000
Gross Profit	400,000	225,000	-1,106,000	2,167,000	909,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	10,690,000	11,674,000	18,451,000	34,128,000	22,031,000
Operating Expenses	19,002,000	16,859,000	29,343,000	51,857,000	32,020,000
Operating Income	-18,602,000	-16,634,000	-29,311,000	-49,690,000	-31,111,000
Interest Expense	212,000	172,000	0	1,412,000	2,454,000
Income Before Tax	-18,377,000	-15,443,000	-29,311,000	-50,304,000	-23,213,000
Income Tax Expense	0	0	-1,639,000	701,000	0
Net Income	-18,377,000	-24,907,000	-29,311,000	-51,005,000	-23,207,000
Per Share
EPS	-1.75	-6.50	-23.94	-2,924.26	-2.97
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for iBio Inc (IBIO).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	8,582,000	14,210,000	4,301,000	22,676,000
Short Term Investments	0	0	0	10,845,000
Net Receivables	105,000	713,000	204,000	6,100,000
Inventory	0	0	21,090,000	3,900,000
Total Current Assets	9,721,000	15,672,000	26,259,000	45,070,000
Property Plant Equipment	5,282,000	6,372,000	7,551,000	41,755,000
Goodwill and Intangibles	6,848,000	5,368,000	5,388,000	4,851,000
Total Assets	23,185,000	28,734,000	41,207,000	99,406,000
Liabilities
Account Payables	2,188,000	358,000	1,849,000	4,264,000
Short Term Debt	1,309,000	953,000	13,598,000	22,308,000
Total Current Liabilities	6,106,000	3,840,000	21,582,000	30,436,000
Long Term Debt	2,199,000	3,507,000	3,476,000	5,485,000
Total Liabilities	8,305,000	7,410,000	25,826,000	35,921,000
Shareholders Equity
Retained Earnings	-332,224,000	-313,847,000	-288,940,000	-223,930,000
Total Shareholders Equity	14,880,000	21,324,000	15,381,000	63,485,000

Balance sheet annual history for iBio Inc (IBIO).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Assets
Cash and Cash Equivalents	8,582,000	14,210,000	4,301,000	22,676,000	77,404,000
Short Term Investments	0	0	0	10,845,000	19,570,000
Net Receivables	105,000	713,000	204,000	6,100,000	5,526,000
Inventory	0	0	21,090,000	3,900,000	27,000
Total Current Assets	9,721,000	15,672,000	26,259,000	45,070,000	104,597,000
Property Plant Equipment	5,282,000	6,372,000	7,551,000	41,755,000	34,739,000
Goodwill and Intangibles	6,848,000	5,368,000	5,388,000	4,851,000	952,000
Total Assets	23,185,000	28,734,000	41,207,000	99,406,000	146,968,000
Liabilities
Account Payables	2,188,000	358,000	1,849,000	4,264,000	2,254,000
Short Term Debt	1,309,000	953,000	13,598,000	22,308,000	967,000
Total Current Liabilities	6,106,000	3,840,000	21,582,000	30,436,000	6,645,000
Long Term Debt	2,199,000	3,507,000	3,476,000	5,485,000	31,755,000
Total Liabilities	8,305,000	7,410,000	25,826,000	35,921,000	38,400,000
Shareholders Equity
Retained Earnings	-332,224,000	-313,847,000	-288,940,000	-223,930,000	-173,627,000
Total Shareholders Equity	14,880,000	21,324,000	15,381,000	63,485,000	108,585,000

Cash flow quarterly history for iBio Inc (IBIO).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	-18,377,000	-24,907,000	-65,010,000	-50,304,000
Depreciation & Amortization	291,000	1,250,000	1,380,000	3,791,000
Stock Based Compensation	1,530,000	2,038,000	4,391,000	4,377,000
Change in Working Capital	479,000	-3,168,000	5,869,000	3,243,000
Operating Cash Flow	-15,304,000	-18,554,000	-30,436,000	-37,480,000
Investing Activities
Capital Expenditure	-16,000	-210,000	-5,738,000	-11,630,000
Investments	-16,000	-210,000	-5,738,000	-11,630,000
Investing Cash Flow	742,000	906,000	7,009,000	-5,127,000
Financing Activities
Debt Repayment	-771,000	-1,138,000	-9,625,000	-5,830,000
Common Stock Issued/Repurchased	9,700,000	25,516,000	11,448,000	77,000
Dividends Paid	0	0	0	0
Financing Cash Flow	8,929,000	24,494,000	2,301,000	-6,125,000
Summary
Free Cash Flow	-15,320,000	-18,764,000	-36,174,000	-49,110,000
Net Change in Cash	-5,633,000	6,846,000	-21,093,000	-48,732,000

Cash flow annual history for iBio Inc (IBIO).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	-18,377,000	-24,907,000	-65,010,000	-50,304,000	-23,207,000
Depreciation & Amortization	291,000	1,250,000	1,380,000	3,791,000	2,414,000
Stock Based Compensation	1,530,000	2,038,000	4,391,000	4,377,000	1,586,000
Change in Working Capital	479,000	-3,168,000	5,869,000	3,243,000	-11,154,000
Operating Cash Flow	-15,304,000	-18,554,000	-30,436,000	-37,480,000	-30,064,000
Investing Activities
Capital Expenditure	-16,000	-210,000	-5,738,000	-11,630,000	-5,162,000
Investments	-16,000	-210,000	-5,738,000	-11,630,000	-4,920,000
Investing Cash Flow	742,000	906,000	7,009,000	-5,127,000	-26,478,000
Financing Activities
Debt Repayment	-771,000	-1,138,000	-9,625,000	-5,830,000	-331,000
Common Stock Issued/Repurchased	9,700,000	25,516,000	11,448,000	77,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	8,929,000	24,494,000	2,301,000	-6,125,000	78,835,000
Summary
Free Cash Flow	-15,320,000	-18,764,000	-36,174,000	-49,110,000	-35,226,000
Net Change in Cash	-5,633,000	6,846,000	-21,093,000	-48,732,000	22,292,000